Edition:
India

Amneal Announces Approval And Launch Of Generic Revatio For Oral Suspension And Generic Amicar Tablets


Tuesday, 3 Dec 2019 

Dec 2 (Reuters) - Amneal Pharmaceuticals Inc ::AMNEAL ANNOUNCES THE APPROVAL AND LAUNCH OF GENERIC REVATIO® FOR ORAL SUSPENSION AND GENERIC AMICAR® TABLETS.AMNEAL PHARMACEUTICALS - RECEIVED FINAL U.S. FDA APPROVAL ON ITS ABBREVIATED NEW DRUG APPLICATIONS FOR GENERIC VERSIONS OF REVATIO.AMNEAL PHARMACEUTICALS INC - HAS IMMEDIATELY INITIATED COMMERCIALIZATION ACTIVITIES.